// App-Quantinova.ai

BSH19‐PO‐106 : Efficacy and Toxicity of Salvage Second Autologous Stem Cell Transplant In Patients with Relapsed Multiple Myeloma

Researchers

Presenter

  • A. Cooper

Principal Investigators

  • A. Rocci

Medical Centers

  • Manchester Royal Infirmary, Manchester, United Kingdom

  • Haematology, Manchester Royal Infirmary,

  • Faculty of Biology, Medicine and Health, School of Medical Science, Division of Cancer Science, The University of Manchester, Manchester, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Oncology (ONC)

Disease

  • Multiple Myeloma

  • Renal insufficiency

Biomarkers

  • C reactive protein

Drug/Treatment

  • Lenalidomide

  • carfilzomib Intravenous

  • Bortezomib

  • Melphalan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved